JP2025517657A5 - - Google Patents

Info

Publication number
JP2025517657A5
JP2025517657A5 JP2024566207A JP2024566207A JP2025517657A5 JP 2025517657 A5 JP2025517657 A5 JP 2025517657A5 JP 2024566207 A JP2024566207 A JP 2024566207A JP 2024566207 A JP2024566207 A JP 2024566207A JP 2025517657 A5 JP2025517657 A5 JP 2025517657A5
Authority
JP
Japan
Prior art keywords
fusion protein
seq
amino acid
acid sequence
protein according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024566207A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025517657A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2023/062497 external-priority patent/WO2023217904A1/en
Publication of JP2025517657A publication Critical patent/JP2025517657A/ja
Publication of JP2025517657A5 publication Critical patent/JP2025517657A5/ja
Pending legal-status Critical Current

Links

JP2024566207A 2022-05-10 2023-05-10 シンシチン-1融合タンパク質及び標的細胞へのカーゴ送達のためのその使用 Pending JP2025517657A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22305688 2022-05-10
EP22305688.8 2022-05-10
PCT/EP2023/062497 WO2023217904A1 (en) 2022-05-10 2023-05-10 Syncitin-1 fusion proteins and uses thereof for cargo delivery into target cells

Publications (2)

Publication Number Publication Date
JP2025517657A JP2025517657A (ja) 2025-06-10
JP2025517657A5 true JP2025517657A5 (https=) 2026-03-06

Family

ID=81984672

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024566207A Pending JP2025517657A (ja) 2022-05-10 2023-05-10 シンシチン-1融合タンパク質及び標的細胞へのカーゴ送達のためのその使用

Country Status (4)

Country Link
US (1) US20250223326A1 (https=)
EP (1) EP4522630A1 (https=)
JP (1) JP2025517657A (https=)
WO (1) WO2023217904A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025257403A1 (en) * 2024-06-14 2025-12-18 Dotbio Pte. Ltd. Virus-like particles
CN118557718A (zh) * 2024-08-01 2024-08-30 中国人民解放军军事科学院军事医学研究院 一种以peg10蛋白为载体的纳米颗粒及其制备方法和应用

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4960716A (en) 1984-05-01 1990-10-02 Ciba Corning Diagnostics Corp. Monoclonal antibodies specific for 330 KD breast tumor antigen and assay using said monoclonal antibodies
US4861719A (en) 1986-04-25 1989-08-29 Fred Hutchinson Cancer Research Center DNA constructs for retrovirus packaging cell lines
US5278056A (en) 1988-02-05 1994-01-11 The Trustees Of Columbia University In The City Of New York Retroviral packaging cell lines and process of using same
EP0368684B2 (en) 1988-11-11 2004-09-29 Medical Research Council Cloning immunoglobulin variable domain sequences.
US5670488A (en) 1992-12-03 1997-09-23 Genzyme Corporation Adenovirus vector for gene therapy
CA2044421C (en) 1990-11-27 2005-06-21 Thomas Hyatt Duffy Squamous cell carcinoma-like immunoreactive antigen from human female urine
AU657102B2 (en) 1991-04-12 1995-03-02 Bio-Rad Laboratories, Inc. CA 195-like immunoreactive antigen from human amniotic fluid
DK1621554T4 (da) 1992-08-21 2012-12-17 Univ Bruxelles Immunoglobuliner blottet for lette kæder
DE69434860T2 (de) 1993-02-22 2007-03-15 The Rockefeller University Herstellung von helfer-freien retroviren mit hohem titer mittels transienter transfektion
FR2712812B1 (fr) 1993-11-23 1996-02-09 Centre Nat Rech Scient Composition pour la production de produits thérapeutiques in vivo.
US6057287A (en) 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
US6740734B1 (en) 1994-01-14 2004-05-25 Biovitrum Ab Bacterial receptor structures
FR2716459B1 (fr) 1994-02-22 1996-05-10 Univ Paris Curie Système hôte-vecteur utilisable en thérapie génique.
IL116816A (en) 1995-01-20 2003-05-29 Rhone Poulenc Rorer Sa Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof
EP0739981A1 (en) 1995-04-25 1996-10-30 Vrije Universiteit Brussel Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes
US6013516A (en) 1995-10-06 2000-01-11 The Salk Institute For Biological Studies Vector and method of use for nucleic acid delivery to non-dividing cells
DE19742706B4 (de) 1997-09-26 2013-07-25 Pieris Proteolab Ag Lipocalinmuteine
SE9901379D0 (sv) 1999-04-19 1999-04-19 Pharmacia & Upjohn Ab Receptor structures
US6602977B1 (en) 1999-04-19 2003-08-05 Biovitrum Ab Receptor structures
US20020052040A1 (en) 1999-06-30 2002-05-02 Nicholas Hunt Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
DE19932688B4 (de) 1999-07-13 2009-10-08 Scil Proteins Gmbh Design von Beta-Faltblatt-Proteinen des gamma-II-kristallins antikörperähnlichen
EP1332209B1 (en) 2000-09-08 2009-11-11 Universität Zürich Collections of repeat proteins comprising repeat modules
US20050053973A1 (en) 2001-04-26 2005-03-10 Avidia Research Institute Novel proteins with targeted binding
US20050089932A1 (en) 2001-04-26 2005-04-28 Avidia Research Institute Novel proteins with targeted binding
US20050048512A1 (en) 2001-04-26 2005-03-03 Avidia Research Institute Combinatorial libraries of monomer domains
US20060223114A1 (en) 2001-04-26 2006-10-05 Avidia Research Institute Protein scaffolds and uses thereof
US20030157561A1 (en) 2001-11-19 2003-08-21 Kolkman Joost A. Combinatorial libraries of monomer domains
US20040175756A1 (en) 2001-04-26 2004-09-09 Avidia Research Institute Methods for using combinatorial libraries of monomer domains
US20030082630A1 (en) 2001-04-26 2003-05-01 Maxygen, Inc. Combinatorial libraries of monomer domains
US20060073141A1 (en) 2001-06-28 2006-04-06 Domantis Limited Compositions and methods for treating inflammatory disorders
DE10324447A1 (de) 2003-05-28 2004-12-30 Scil Proteins Gmbh Generierung künstlicher Bindungsproteine auf der Grundlage von Ubiquitin
US20050164301A1 (en) 2003-10-24 2005-07-28 Avidia Research Institute LDL receptor class A and EGF domain monomers and multimers
DK1773872T3 (en) 2004-05-21 2017-05-08 Uab Res Found VARIABLE Lymphocyte Receptors, Associated Polypeptides and Nucleic Acids, and Uses thereof
US20060008844A1 (en) 2004-06-17 2006-01-12 Avidia Research Institute c-Met kinase binding proteins
US7563443B2 (en) 2004-09-17 2009-07-21 Domantis Limited Monovalent anti-CD40L antibody polypeptides and compositions thereof
US20060234299A1 (en) 2004-11-16 2006-10-19 Avidia Research Institute Protein scaffolds and uses thereof
IL310721B2 (en) 2015-10-23 2025-11-01 Harvard College Nucleobase editors and uses thereof
EP3235828A1 (en) 2016-04-21 2017-10-25 Genethon Stable pseudotyped lentiviral particles and uses thereof
CN110214183A (zh) 2016-08-03 2019-09-06 哈佛大学的校长及成员们 腺苷核碱基编辑器及其用途
EP3284819A1 (en) 2016-08-16 2018-02-21 Max-Delbrück-Centrum für Molekulare Medizin (MDC) Method for the generation of t cell hybridoma for cloning and analysis of receptors using engineered measles virus fusogenic glycoproteins
CA3078096A1 (en) * 2017-10-20 2018-10-19 Genethon Use of syncytin for targeting drug and gene delivery to regenerating muscle tissue
IL273923B2 (en) * 2017-10-20 2024-08-01 Genethon Using syncytin for drug targeting and gene delivery to lung tissue
JP7693552B2 (ja) 2019-02-13 2025-06-17 ビーム セラピューティクス インク. アデノシンデアミナーゼ塩基エディターおよびそれを用いて標的配列中の核酸塩基を改変する方法
US20220184225A1 (en) * 2019-04-23 2022-06-16 Case Western Reserve University Fusogenic particles and related methods for delivering therapeutic agents to cells
AU2020344547A1 (en) 2019-09-09 2022-03-24 Beam Therapeutics Inc. Novel nucleobase editors and methods of using same

Similar Documents

Publication Publication Date Title
JP2023126852A5 (https=)
JP2019533450A5 (https=)
FI3535392T3 (fi) Immunologisesti havaittavia solupintavariantteja käytettäväksi soluterapiassa
HRP20200251T1 (hr) Proizvodnja i korištenje vitro-sintetizirane ssrna za uvođenje u ćelije sisavaca za proizvodnju biološkog ili biokemijskog učinka
JP2025517657A5 (https=)
JP2023515199A5 (https=)
IL295897A (en) Materials and methods for modulating an immune response
US12153043B2 (en) Bi-specific probes to enable the use of single-cell samples as single color compensation control
JP2025513879A5 (https=)
US20060003452A1 (en) Vector packaging cell line
JP2004528806A5 (https=)
JP2024506682A5 (https=)
JP2023537534A5 (https=)
US20140023592A1 (en) Self coupling recombinant antibody fusion proteins
JP2025516377A (ja) 多重特異性抗体を含む治療薬及び腫瘍治療におけるその使用
EP4214318A1 (en) Compositions and methods for cd7 modification
JP2025519106A5 (https=)
US20240417755A1 (en) Fusion polypeptides for genetic editing and methods of use thereof
EP4582456A1 (en) Strengthened receptor, and immune cell expressing strengthened receptor and use thereof
US20250223326A1 (en) Syncitin-1 fusion proteins and uses thereof for cargo delivery into target cells
WO2022217086A1 (en) Photocleavable guide rnas and methods of use thereof
AU2022387087A1 (en) Compositions and methods for erm2 modification
US20240384304A1 (en) Inhibitor oligonucleotides and methods of use thereof
US20240344058A1 (en) Compositions and methods for bcma modification
RU2793803C2 (ru) Иммунологически отличимые варианты поверхности клеток для применения в клеточной терапии